Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.
2.
3.

Comparative strain analysis of Anaplasma phagocytophilum infection and clinical outcomes in a canine model of granulocytic anaplasmosis.

Scorpio DG, Dumler JS, Barat NC, Cook JA, Barat CE, Stillman BA, DeBisceglie KC, Beall MJ, Chandrashekar R.

Vector Borne Zoonotic Dis. 2011 Mar;11(3):223-9. doi: 10.1089/vbz.2009.0262. Epub 2010 Sep 16.

PMID:
20846015
4.

Stat1 negatively regulates immune-mediated injury with Anaplasma phagocytophilum infection.

Choi KS, Scorpio DG, Dumler JS.

J Immunol. 2014 Nov 15;193(10):5088-98. doi: 10.4049/jimmunol.1401381. Epub 2014 Oct 10.

5.

Anaplasma phagocytophilum surface protein AipA mediates invasion of mammalian host cells.

Seidman D, Ojogun N, Walker NJ, Mastronunzio J, Kahlon A, Hebert KS, Karandashova S, Miller DP, Tegels BK, Marconi RT, Fikrig E, Borjesson DL, Carlyon JA.

Cell Microbiol. 2014 Aug;16(8):1133-45. doi: 10.1111/cmi.12286. Epub 2014 Apr 3.

6.

Human granulocytic anaplasmosis.

Pozdnyakova O, Dorfman DM.

Blood. 2012 Dec 13;120(25):4911. No abstract available.

7.

Experimental infection of white-tailed deer with Anaplasma phagocytophilum, etiologic agent of human granulocytic anaplasmosis.

Tate CM, Mead DG, Luttrell MP, Howerth EW, Dugan VG, Munderloh UG, Davidson WR.

J Clin Microbiol. 2005 Aug;43(8):3595-601.

8.

Differential innate immune cell activation and proinflammatory response in Anaplasma phagocytophilum infection.

Choi KS, Webb T, Oelke M, Scorpio DG, Dumler JS.

Infect Immun. 2007 Jun;75(6):3124-30. Epub 2007 Apr 2.

9.

Epidemiology and control of human granulocytic anaplasmosis: a systematic review.

Jin H, Wei F, Liu Q, Qian J.

Vector Borne Zoonotic Dis. 2012 Apr;12(4):269-74. doi: 10.1089/vbz.2011.0753. Epub 2012 Jan 4. Review.

PMID:
22217177
10.

Interferon-γ-dependent control of Anaplasma phagocytophilum by murine neutrophil granulocytes.

Gussmann K, Kirschnek S, von Loewenich FD.

Parasit Vectors. 2017 Jul 12;10(1):329. doi: 10.1186/s13071-017-2274-6.

11.

Dissociation between inhibition and killing by levofloxacin in human granulocytic anaplasmosis.

Wormser GP, Filozov A, Telford SR 3rd, Utpat S, Kamer RS, Liveris D, Wang G, Zentmaier L, Schwartz I, Aguero-Rosenfeld ME.

Vector Borne Zoonotic Dis. 2006 Winter;6(4):388-94.

PMID:
17187574
13.

The elimination of Anaplasma phagocytophilum requires CD4+ T cells, but is independent of Th1 cytokines and a wide spectrum of effector mechanisms.

Birkner K, Steiner B, Rinkler C, Kern Y, Aichele P, Bogdan C, von Loewenich FD.

Eur J Immunol. 2008 Dec;38(12):3395-410. doi: 10.1002/eji.200838615.

14.

Gene expression profiling of human promyelocytic cells in response to infection with Anaplasma phagocytophilum.

de la Fuente J, Ayoubi P, Blouin EF, Almazán C, Naranjo V, Kocan KM.

Cell Microbiol. 2005 Apr;7(4):549-59.

PMID:
15760455
15.

Alkali-induced corneal neovascularization is independent of CXCR2-mediated neutrophil infiltration.

Lu P, Li L, Mukaida N, Zhang X.

Cornea. 2007 Feb;26(2):199-206.

PMID:
17251813
16.

Msp2 variation in Anaplasma phagocytophilum in vivo does not stimulate T cell immune responses or interferon-gamma production.

Choi KS, Scorpio DG, Barat NC, Stephen Dumler J.

FEMS Immunol Med Microbiol. 2007 Apr;49(3):374-86. Epub 2007 Feb 7.

17.

Experimental infection of C3H/HeJ mice with the NY18 isolate of Anaplasma phagocytophilum.

Blas-Machado U, de la Fuente J, Blouin EF, Almazán C, Kocan KM, Mysore JV.

Vet Pathol. 2007 Jan;44(1):64-73.

PMID:
17197625
18.
19.

Laboratory Maintenance of Anaplasma phagocytophilum.

Carlyon JA.

Curr Protoc Microbiol. 2005 Jul;Chapter 3:Unit 3A.2. doi: 10.1002/9780471729259.mc03a02s00.

PMID:
18770564
20.

Insights into pathogen immune evasion mechanisms: Anaplasma phagocytophilum fails to induce an apoptosis differentiation program in human neutrophils.

Borjesson DL, Kobayashi SD, Whitney AR, Voyich JM, Argue CM, Deleo FR.

J Immunol. 2005 May 15;174(10):6364-72.

Supplemental Content

Support Center